Anthony Letai was Named as the New Director of NIH's National Cancer Institute

Anthony Letai

Rare Cancer Day 2025: Illuminating the Hidden Frontiers of Oncology

Rare Cancer Day 2025

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Julie Gralow: Let’s Push for Dose Optimization for All Cancer Treatments

Julie Gralow

Visa Restrictions Threaten U.S. Health Care Workforce

Visa Restrictions

Hesham ElGhazaly: Egypt’s Voice and Commitment to Global Collaboration

Hesham ElGhazaly

Carlos Rodriguez-Galindo: GICC Progress Spotlighted at UNGA 80

Carlos Rodriguez-Galindo

Triple Combination of Encorafenib, Cetuximab, and Nivolumab in MSS BRAFV600E Metastatic Colorectal Cancer

nivolumab encorafenib cetuximab for brafv600e MSS CRC

David Thomson